bacTRL-IL-12 / Symvivo - LARVOL DELTA

Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours (clinicaltrials.gov) - P1; N=5; Terminated; Sponsor: Iqvia Pty Ltd; N=38 ➔ 5; Recruiting ➔ Terminated; Sponsor decision

Clinical • Enrollment change • Trial termination • Oncology • Solid Tumor

Phase I Trial of bacTRL-IL-12 in Adult Subjects With Advanced, Treatment-refractory Solid Tumours (clinicaltrials.gov) - P1; N=38; Recruiting; Sponsor: Iqvia Pty Ltd; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open